Versiti - Eight VBRI Scientists Named to Stanford/Elsevier World's Top 2% Scientists List

News

Eight VBRI Scientists Earn Recognition on Stanford and Elsevier’s Top 2% List

Milwaukee — March 02, 2026
 

For scientists, the measure of their work is often found not just in what they discover, but in how often those discoveries move others forward. Citations, the act of one researcher building on another's published findings, are among the most meaningful signals of a scientist's influence in a field. By that measure, the researchers of the Versiti Blood Research Institute (VBRI) are among the most influential in the world. 

Stanford University and academic publisher Elsevier's annual list of the World's Top 2% Scientists has recognized eight VBRI investigators in its most recent update. The list is compiled using Scopus citation data and a composite scoring methodology. The inclusion of eight VBRI scientists in the rankings matches the institute's strongest showing since the rankings were established.

About the Ranking

The list is widely recognized as one of the most rigorous independent measures of scientific impact. Researchers are scored using six citation-based metrics, including total citations, h-index, and co-authorship-adjusted indicators, and ranked across 22 scientific fields and 174 sub-fields. Scientists must rank in the top 2% of their sub-field, or within the top 100,000 researchers globally, to be included.

The list is published in two versions: one measuring career-long impact across a researcher's full body of published work, and one reflecting impact in the past year, highlighting research that is drawing the most attention right now.

Recognized on Both the Career and Current-Year Lists

Three VBRI investigators earned recognition on both lists, a distinction that reflects both a lifetime of consequential research and work that continues to shape the field today:

Recognized for Career-Long Impact

Two investigators were recognized for the breadth and staying power of their contributions across their careers:

Recognized for Current-Year Impact

Three investigators were recognized for their impact in the most recent year of the ranking, reflecting research that is actively shaping science and standards of care:

Research That Compounds

The reach of VBRI's science extends well beyond its Milwaukee campus. Citations are, at their core, show when another scientist, somewhere in the world, finds that the work done at VBRI is indispensable to the work they are doing

VBRI’s work spans basic, translational, and clinical research in hematology, with investigators focused on everything from blood clotting disorders and platelet biology to immune regulation, glycobiology, and transfusion medicine. When that science is cited by peers at institutions around the world, it is evidence that the questions being asked here — and the answers that follow — matter to the field.

 

The Versiti Blood Research Institute is dedicated to advancing hematology through basic, translational, and clinical research. Located on the Milwaukee Regional Medical Center campus alongside the Medical College of Wisconsin, Froedtert Hospital, and Children's Wisconsin, VBRI provides investigators with state-of-the-art facilities and specialized core services to accelerate discovery. For more information, visit investinhope.versiti.org.

 
Before Versiti Asked the World to Invest in Hope, We Asked the People Who Know This Work Best
An internal giving campaign among Versiti employees  now opens to the public as a $79 million call to advance blood health for everyone.
 
MACC Fund Commits $11.5 Million to Propel Pediatric Cancer Research at Versiti Blood Research Institute
The MACC Fund has committed $11.5 million to advance pediatric cancer research at the Versiti Blood Research Institute, strengthening a long-standing partnership dedicated to improving outcomes for children facing leukemia and other blood disorders.